Navigation Links
Shock Fear May Curb Sex for People With Heart Devices
Date:11/14/2011

By Denise Mann
HealthDay Reporter

MONDAY, Nov. 14 (HealthDay News) -- For people with implantable cardioverter defibrillators, the life-saving device may come at a cost: Fear of it firing a shock to the heart during sex drives some to avoid lovemaking altogether.

Implantable cardioverter defibrillators (ICD) are small devices placed in the chest or abdomen that shoot off electrical pulses when they detect potentially life-threatening, irregular heartbeats.

But shock-related anxiety can impede sexual performance, according to new research scheduled for presentation Tuesday at the American Heart Association annual meeting in Orlando, Fla.

These fears are warranted, said study author Dr. Steven Cook, director of adult congenital heart disease at Children's Hospital of Pittsburgh. "It's a huge deal that no one talks about sexual function with these patients," Cook said.

ICDs can fire during sex or any other time that they sense a dangerous arrhythmia, Cook added. And the jolt can be frightening. He said that patients tell him the shock feels like "someone kicked you in the chest. It is a pretty intense sensation."

The new study included 151 men and women who had congenital heart disease, meaning a heart abnormality since birth. Of these, 41 had ICDs and an average age of 37. Those without an ICD averaged 32 years. Study participants rated their sexual function and depression via standardized tools, which included questions about confidence, satisfaction and arousal. Those individuals with ICDs also completed the Florida Shock Anxiety Scale, which measures fears about ICD-related shock.

Men with ICDs had sexual function scores similar to the ratings of men with mild erectile dysfunction (the inability to achieve or maintain an erection sufficient for sexual intercourse).

The sexual function scores of women with and without ICDs showed little difference, suggesting men might be more affected by shock-related anxiety.

Many people with congenital heart disease may be depressed, which could affect their sexual function, but depression scores were in the normal range for all of the study participants -- those with and without ICDs, the study showed.

Men and women who reported high levels of shock-related anxiety had lower sexual function scores compared with their counterparts who were not anxious about their device firing. It didn't matter if these individuals were single or in committed relationships. Some may have experienced a shock in the past, while others might just fear experiencing one in the future, Cook said.

Communication between patients and their doctors is critical to allay any fears, Cook said. Anyone shocked in the past who dreads another jolt should try to figure out why the device fired in the first place, Cook said.

Solutions exist, based on whether the ICD fired appropriately or inappropriately. Doctors can tweak your medication regimen to help control the underlying heart problem or reprogram the device, he said.

In the future, it may help to have doctors screen people for shock-related anxiety before implanting the device, he said.

This is a real issue, said Dr. Joshua M. Hare, the Louis Lemberg Professor of Medicine at the University of Miami Miller School of Medicine. "It is an interesting dilemma because the same device that can save your life also has side effects," he said.

"It's the right treatment, but there is the risk that it could happen at the wrong time," he said. "If you don't have the device you are at risk for a potentially fatal event, but having the device can be anxiety-provoking and create psychosocial issues."

"You have to pick your poison," he said.

Research presented at meetings should be considered preliminary until published in a peer-reviewed medical journal.

More information

Find out more about implantable cardioverter devices at the U.S. National Heart, Lung, and Blood Institute.

SOURCES: Steven Cook, M.D., director, adult congenital heart disease, Children's Hospital of Pittsburgh; Joshua M. Hare, M.D., the Louis Lemberg Professor of Medicine, University of Miami Miller School of Medicine, Fla.; Nov. 15, 2011, presentation, American Heart Association annual meeting, Orlando, Fla.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. For a Healthier, Cleaner Fitness Regimen - Venture Products Shock Athletic(TM) Mats and Interlocking Flooring
2. BUAV Exposes Shocking Role Played by Laos in the International Trade in Primates for Research
3. Safety data favor norepinephrine over dopamine for shock
4. Hearts of Hospice Patients Being Needlessly Shocked
5. New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Louisiana is 46th Among All States in Maternal Mortality
6. New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Georgia is 50th Among All States in Maternal Mortality
7. New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Maryland is 48th Among All States in Maternal Mortality
8. New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; District of Columbia is 51st Among All States in Maternal Mortality
9. New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Arkansas is 44th Among All States in Maternal Mortality
10. New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Delaware is 42nd Among All States in Maternal Mortality
11. New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Mississippi is 45th Among All States in Maternal Mortality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... From April ... of Urgent Care Medicine will host industry leaders for the annual spring Convention ... those in the industry adapt to the issues currently affecting urgent care and ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to ... “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa wore his ... of Greater Boston, in a NALA North American Speaker Series (NASS) segment. ...
(Date:4/28/2017)... ... ... Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has published a ... does not. Yisrayl says with so many titles and names for the Creator, it’s ... with a little Scripture, backed with a lot of research, the truth is undeniable. ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... for the North East region. Côté has 20+ years of experience within the ... Phytomer, Côté worked with an array of high-end cosmetic brands, retail brands and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... advanced nutraceutical supplements, through its Nova Skin Sciences division, recently announced the launch ... a moisturizer with the power of an anti-aging concentrate. , Anogeissus ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 Research and Markets ... Pipeline and Market Prospects: Addressing Production Complexities Through Risk ... offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities ... in-depth assessment of the current trends in the global ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
Breaking Medicine Technology: